BOTHELL, Wash.--(BUSINESS WIRE)--Sonus Pharmaceuticals, Inc. (NASDAQ: SNUS), an oncology drug development company, today reported progress and financial results for the first quarter of 2007. At 4:30 P.M. ET today, Sonus will host its quarterly conference call. The discussion will include an overview of the progress with the Company’s first two oncology product candidates, TOCOSOL® Paclitaxel and TOCOSOL Camptothecin.
